IP Library › Granted Patent US 12,721,575
Granted Patent B2
US 12,721,575 · App. 19/000,802 · Granted Sep 1, 2026

Monitoring physiological status based on bio-vibrational and radio frequency data analysis

Inventors: Kent Volosin (Mars, PA); Gary A. Freeman (Waltham, MA)
Assignee: ZOLL Medical Corporation
A61B5/7275A61B5/05A61B5/0535A61B5/1102A61B5/366A61B5/7264H04Q9/00A61B2562/0219
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,721,575
App. No.
19/000,802
Granted
Sep 1, 2026
Kind
B2
Abstract

A patient monitoring device includes an ECG sensor coupled to a patient, a sensor coupled to the patient and configured to detect bio-vibrational signals, and a radiofrequency monitoring device configured to produce information responsive to electromagnetic energy reflected from the patient's thoracic cavity. A processor processes the ECG signals, the bio-vibrational signals, and the radio frequency information to generate a plurality of physiological parameters of the patient. The processor also performs at least one of a predictive analysis and a trend analysis of the plurality of physiological parameters to determine a current clinical condition of the patient. The trend analysis includes determining a substantial relationship between changes in the plurality of physiological parameters. The processor can also compare the current clinical condition of the patient to predetermined clinically actionable criteria to determine one or more clinically actionable events and provide an output relating to one or more clinically actionable events.

Claims (60)

1 . A system for generating and processing physiological parameters, the system comprising:

an externally worn cardiac monitor configured to be worn by a patient during a prescribed period of use, the externally worn cardiac monitor comprising:

an electrocardiogram sensor configured to detect one or more electrocardiogram signals of the patient,

a cardio-vibrational sensor configured to detect one or more cardio-vibrational signals of the patient,

one or more radiofrequency antennas and associated radiofrequency circuitry to produce radiofrequency information responsive to radiofrequency energy reflected from within a thoracic cavity of the patient, and

one or more device processors configured to

process the one or more electrocardiogram signals and the one or more cardio-vibrational signals to generate electromechanical activation parameter data for the patient for a monitoring interval,

process the radiofrequency information to generate thoracic fluid content data for the patient for the monitoring interval,

perform a trend analysis on the electromechanical activation parameter data and the thoracic fluid content data to identify a substantial relationship between the electromechanical activation parameter data and the thoracic fluid content data, and

cause an output device to provide a first output representing at least a first portion of the monitoring interval, wherein the first output visually depicts the substantial relationship.

2 . The system of claim 1 , wherein the cardio-vibrational sensor comprises an accelerometer.

3 . The system of claim 1 , wherein the one or more device processors are further configured to:

determine a current clinical condition of the patient based on the trend analysis;

compare the current clinical condition of the patient to predetermined clinically actionable criteria to identify a clinically actionable event; and

cause the output device to provide a second output relating to the clinically actionable event.

4 . The system of claim 3 , wherein the clinically actionable event is either:

an automated event that is triggered without user input; or

a manual event that is triggered based upon a user response to the second output relating to the clinically actionable event.

5 . The system of claim 3 , wherein the second output relating to the clinically actionable event comprises an instruction to perform an action.

6 . The system of claim 1 , wherein the one or more device processors are further configured to:

input the electromechanical activation parameter data and the thoracic fluid content data into a machine learning algorithm; and

determine a current clinical condition of the patient based upon on output of the machine learning algorithm.

7 . The system of claim 6 , wherein:

the current clinical condition of the patient comprises a predictive score based upon the output of the machine learning algorithm; and

the predictive score indicates a likelihood of an occurrence of an adverse event for the patient.

8 . The system of claim 7 , wherein the adverse event for the patient comprises one or more of an arrhythmia event for the patient, a stroke event for the patient, a syncopal event for the patient, or a hospitalization event for the patient.

9 . The system of claim 1 , wherein the one or more device processors are further configured to process the one or more cardio-vibrational signals over at least a second portion of the monitoring interval to determine a cardiac vibrational metric of the patient.

10 . The system of claim 9 , wherein the one or more device processors are further configured to:

make a determination that the thoracic fluid content data exceeds a threshold during at least a third portion of the monitoring interval; and

after making the determination, monitor the cardiac vibrational metric during a subsequent monitoring interval.

11 . The system of claim 9 , wherein the cardiac vibrational metric is one or more of a heart vibration intensity value, a pulmonary vibration intensity value, or a left ventricular systolic time.

12 . A system for monitoring physiological parameters of a patient, the system comprising:

an externally worn cardiac monitor configured to be bodily-attached to a patient during a prescribed period of use, the externally worn cardiac monitor comprising:

an electrocardiogram sensor configured to detect one or more electrocardiogram signals of the patient,

a microphone configured to detect one or more cardio-vibrational signals of the patient,

a radiofrequency transceiver circuit comprising one or more antennas configured to direct radiofrequency energy into the patient, wherein the radiofrequency transceiver circuit is configured to produce radiofrequency information responsive to reflected radiofrequency energy that is reflected from within the patient and received through the one or more antennas, and

one or more device processors configured to

during a monitoring interval within the prescribed period of use, process the one or more electrocardiogram signals and the one or more cardio-vibrational signals to generate electromechanical activation parameter data for the monitoring interval, and

during the monitoring interval, process the radiofrequency information to generate thoracic fluid content data for the monitoring interval; and

a remote server comprising one or more server processors and a network interface, the one or more server processors configured to:

receive, via the network interface, the electromechanical activation parameter data and the thoracic fluid content data for the monitoring interval,

perform a trend analysis on the electromechanical activation parameter data and the thoracic fluid content data to identify a substantial relationship between the electromechanical activation parameter data and the thoracic fluid content data, and

cause an output device to provide a first output representing at least a first portion of the monitoring interval, wherein the first output visually depicts the substantial relationship.

13 . The system of claim 12 , wherein the one or more server processors are further configured to:

determine a current clinical condition of the patient based on the trend analysis;

compare the current clinical condition of the patient to predetermined clinically actionable criteria to identify a clinically actionable event; and

cause the output device to provide a second output relating to the clinically actionable event.

14 . The system of claim 13 , wherein the second output relating to the clinically actionable event comprises an instruction to perform an action.

15 . The system of claim 12 , wherein the one or more server processors are further configured to:

input the electromechanical activation parameter data and the thoracic fluid content data into a neural networks algorithm; and

determine a current clinical condition of the patient based upon on output of the neural networks algorithm.

16 . The system of claim 15 , wherein:

the current clinical condition of the patient comprises a predictive score based upon the output of the neural networks algorithm; and

the predictive score indicates a likelihood of an occurrence of an adverse event for the patient.

17 . The system of claim 16 , wherein the adverse event for the patient comprises one or more of an arrhythmia event for the patient, a stroke event for the patient, a syncopal event for the patient, or a hospitalization event for the patient.

18 . The system of claim 12 , wherein the one or more server processors are further configured to process the detected one or more cardio-vibrational signals over at least a second portion of the monitoring interval to determine a cardiac vibrational metric of the patient.

19 . The system of claim 18 , wherein the one or more server processors are further configured to:

make a determination that the thoracic fluid content data exceeds a threshold during at least a third portion of the monitoring interval; and

after making the determination, monitor the cardiac vibrational metric during a subsequent monitoring interval.

20 . The system of claim 18 , wherein the cardiac vibrational metric is one or more of a heart vibration intensity value, a pulmonary vibration intensity value, or a left ventricular systolic time.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 24, 2024
From: VOLOSIN, KENT; FREEMAN, GARY A.
To: ZOLL MEDICAL CORPORATION
Reel/Frame 069672/0980 →
Continuity (5)
Continuation 18494359 · Oct 25, 2023
Continuation 17156919 · Jan 25, 2021
Continuation 16355171 · Mar 15, 2019
Provisional Application 62644216 · Mar 16, 2018
Related Publication 20250318787A1 · Oct 16, 2025
References Cited (168)
US 4576170A · Bradley et al. · 1986 [cited by applicant]
US 4580572A · Granek et al. · 1986 [cited by applicant]
US 4583547A · Granek et al. · 1986 [cited by applicant]
US 4729377A · Granek et al. · 1988 [cited by applicant]
US 4928690A · Heilman et al. · 1990 [cited by applicant]
US 4991217A · Garrett et al. · 1991 [cited by applicant]
US 5078134A · Heilman et al. · 1992 [cited by applicant]
US 5741306A · Glegyak et al. · 1998 [cited by applicant]
US 5929601A · Kaib et al. · 1999 [cited by applicant]
US 5944669A · Kaib · 1999 [cited by applicant]
US 6016445A · Baura · 2000 [cited by applicant]
US 6065154A · Hulings et al. · 2000 [cited by applicant]
US 6097982A · Glegyak et al. · 2000 [cited by applicant]
US 6253099B1 · Oskin et al. · 2001 [cited by applicant]
US 6280461B1 · Glegyak et al. · 2001 [cited by applicant]
US 6336900B1 · Alleckson et al. · 2002 [cited by applicant]
US 6374138B1 · Owen et al. · 2002 [cited by applicant]
US 6406426B1 · Reuss et al. · 2002 [cited by applicant]
US 6546285B1 · Owen et al. · 2003 [cited by applicant]
US 6681003B2 · Linder et al. · 2004 [cited by applicant]
US 6889078B2 · Struble et al. · 2005 [cited by applicant]
US 6889079B2 · Bocek et al. · 2005 [cited by applicant]
US 6908437B2 · Bardy · 2005 [cited by applicant]
US 7122012B2 · Bouton et al. · 2006 [cited by applicant]
US 7149579B1 · Koh et al. · 2006 [cited by applicant]
US 7340296B2 · Stahmann et al. · 2008 [cited by applicant]
US 7453354B2 · Reiter et al. · 2008 [cited by applicant]
US 7476206B2 · Palazzolo et al. · 2009 [cited by applicant]
US 7488293B2 · Marcovecchio et al. · 2009 [cited by applicant]
US 7712373B2 · Nagle et al. · 2010 [cited by applicant]
US 7725150B2 · Tupin, Jr. et al. · 2010 [cited by applicant]
US 7831303B2 · Rueter et al. · 2010 [cited by applicant]
US 7974689B2 · Volpe et al. · 2011 [cited by applicant]
US 7991460B2 · Fischell et al. · 2011 [cited by applicant]
US 8121683B2 · Bucher et al. · 2012 [cited by applicant]
US 8140154B2 · Donnelly et al. · 2012 [cited by applicant]
US 8271082B2 · Donnelly et al. · 2012 [cited by applicant]
US 8369944B2 · Macho et al. · 2013 [cited by applicant]
US 8406842B2 · Kaib et al. · 2013 [cited by applicant]
US 8412323B2 · Bauer · 2013 [cited by applicant]
US 8644925B2 · Volpe et al. · 2014 [cited by applicant]
US 8649861B2 · Donnelly et al. · 2014 [cited by applicant]
US 8676313B2 · Volpe et al. · 2014 [cited by applicant]
US 8706215B2 · Kaib et al. · 2014 [cited by applicant]
US 8774917B2 · Macho et al. · 2014 [cited by applicant]
US 8880196B2 · Kaib · 2014 [cited by applicant]
US 8897860B2 · Volpe et al. · 2014 [cited by applicant]
US 8904214B2 · Volpe et al. · 2014 [cited by applicant]
US 8989837B2 · Weinstein et al. · 2015 [cited by applicant]
US 9002427B2 · Tupin, Jr. et al. · 2015 [cited by applicant]
US 9283399B2 · Donnelly et al. · 2016 [cited by applicant]
US 9675251B2 · Saroka et al. · 2017 [cited by applicant]
US 10595775B2 · Soykan · 2020 [cited by applicant]
US 10932726B2 · Volosin et al. · 2021 [cited by applicant]
US 11826174B2 · Volosin · 2023 [cited by examiner]
US 20010031991A1 · Russial · 2001 [cited by applicant]
US 20020032386A1 · Sackner · 2002 [cited by examiner]
US 20030004547A1 · Owen et al. · 2003 [cited by applicant]
US 20030032988A1 · Fincke · 2003 [cited by applicant]
US 20030095648A1 · Kaib et al. · 2003 [cited by applicant]
US 20050131465A1 · Freeman et al. · 2005 [cited by applicant]
US 20060030781A1 · Shennib · 2006 [cited by applicant]
US 20060036292A1 · Smith et al. · 2006 [cited by applicant]
US 20060111641A1 · Manera et al. · 2006 [cited by applicant]
US 20060211934A1 · Hassonjee et al. · 2006 [cited by applicant]
US 20060264776A1 · Stahmann et al. · 2006 [cited by applicant]
US 20060293714A1 · Salo et al. · 2006 [cited by applicant]
US 20070161913A1 · Farrell et al. · 2007 [cited by applicant]
US 20070265671A1 · Roberts et al. · 2007 [cited by applicant]
US 20080033495A1 · Kumar · 2008 [cited by applicant]
US 20080306560A1 · Macho et al. · 2008 [cited by applicant]
US 20080306562A1 · Donnelly et al. · 2008 [cited by applicant]
US 20080312709A1 · Volpe et al. · 2008 [cited by applicant]
US 20090076363A1 · Bly et al. · 2009 [cited by applicant]
US 20090076405A1 · Amurthur et al. · 2009 [cited by applicant]
US 20090076410A1 · Libbus et al. · 2009 [cited by applicant]
US 20090076559A1 · Libbus et al. · 2009 [cited by applicant]
US 20090093687A1 · Telfort et al. · 2009 [cited by applicant]
US 20090138059A1 · Ouwerkerk · 2009 [cited by applicant]
US 20090234410A1 · Libbus et al. · 2009 [cited by applicant]
US 20090240133A1 · Friedman et al. · 2009 [cited by applicant]
US 20090264792A1 · Mazar · 2009 [cited by applicant]
US 20090292194A1 · Libbus et al. · 2009 [cited by applicant]
US 20090312650A1 · Maile et al. · 2009 [cited by applicant]
US 20100052892A1 · Allen et al. · 2010 [cited by applicant]
US 20100069735A1 · Berkner · 2010 [cited by applicant]
US 20100076533A1 · Dar et al. · 2010 [cited by applicant]
US 20100234716A1 · Engel · 2010 [cited by applicant]
US 20100256462A1 · Rappaport et al. · 2010 [cited by applicant]
US 20100298899A1 · Donnelly · 2010 [cited by examiner]
US 20100312297A1 · Volpe et al. · 2010 [cited by applicant]
US 20110022105A9 · Owen et al. · 2011 [cited by applicant]
US 20110060215A1 · Tupin, Jr. et al. · 2011 [cited by applicant]
US 20110105932A1 · Bauer et al. · 2011 [cited by applicant]
US 20110130800A1 · Weinstein et al. · 2011 [cited by applicant]
US 20110170692A1 · Konrad et al. · 2011 [cited by applicant]
US 20110245688A1 · Arora et al. · 2011 [cited by applicant]
US 20110288604A1 · Kaib et al. · 2011 [cited by applicant]
US 20110288605A1 · Kaib et al. · 2011 [cited by applicant]
US 20120011382A1 · Volpe et al. · 2012 [cited by applicant]
US 20120112903A1 · Kaib et al. · 2012 [cited by applicant]
US 20120146797A1 · Oskin et al. · 2012 [cited by applicant]
US 20120150008A1 · Kaib et al. · 2012 [cited by applicant]
US 20120158075A1 · Kaib et al. · 2012 [cited by applicant]
US 20120283794A1 · Kaib et al. · 2012 [cited by applicant]
US 20120289809A1 · Kaib et al. · 2012 [cited by applicant]
US 20120293323A1 · Kaib et al. · 2012 [cited by applicant]
US 20120302860A1 · Volpe et al. · 2012 [cited by applicant]
US 20130013014A1 · Donnelly et al. · 2013 [cited by applicant]
US 20130060103A1 · Bergida et al. · 2013 [cited by applicant]
US 20130060149A1 · Song et al. · 2013 [cited by applicant]
US 20130085538A1 · Volpe et al. · 2013 [cited by applicant]
US 20130144355A1 · Macho et al. · 2013 [cited by applicant]
US 20130218252A1 · Kaib et al. · 2013 [cited by applicant]
US 20130231711A1 · Kaib · 2013 [cited by applicant]
US 20130282149A1 · Kuntagod et al. · 2013 [cited by applicant]
US 20130324868A1 · Kaib et al. · 2013 [cited by applicant]
US 20130325078A1 · Whiting et al. · 2013 [cited by applicant]
US 20130325096A1 · Dupelle et al. · 2013 [cited by applicant]
US 20140155762A1 · Maskara et al. · 2014 [cited by applicant]
US 20140163334A1 · Volpe et al. · 2014 [cited by applicant]
US 20140206974A1 · Volpe et al. · 2014 [cited by applicant]
US 20140277243A1 · Maskara et al. · 2014 [cited by applicant]
US 20140288610A1 · Freeman · 2014 [cited by applicant]
US 20140303680A1 · Donnelly et al. · 2014 [cited by applicant]
US 20140324112A1 · Macho et al. · 2014 [cited by applicant]
US 20150005588A1 · Herken et al. · 2015 [cited by applicant]
US 20150035654A1 · Kaib et al. · 2015 [cited by applicant]
US 20150039042A1 · Amsler et al. · 2015 [cited by applicant]
US 20150039053A1 · Kaib et al. · 2015 [cited by applicant]
US 20150080699A1 · Kaib et al. · 2015 [cited by applicant]
US 20150224330A1 · Kaib et al. · 2015 [cited by applicant]
US 20160135706A1 · Sullivan et al. · 2016 [cited by applicant]
US 20160163187A1 · Treacy et al. · 2016 [cited by applicant]
US 20160235331A1 · Iskander et al. · 2016 [cited by applicant]
US 20160270738A1 · Volpe et al. · 2016 [cited by applicant]
US 20160345845A1 · Ravid et al. · 2016 [cited by applicant]
US 20170065823A1 · Kaib et al. · 2017 [cited by applicant]
US 20170143977A1 · Kaib et al. · 2017 [cited by applicant]
CN 101553163A · 2009 [cited by applicant]
CN 105942997A · 2016 [cited by applicant]
CN 105992552A · 2016 [cited by applicant]
CN 106132286A · 2016 [cited by applicant]
JP 2002514107A · 2002 [cited by applicant]
JP 2008302225A2 · 2008 [cited by applicant]
JP 2008302228A · 2008 [cited by applicant]
JP 2009510631A · 2009 [cited by applicant]
JP 2010537767A2 · 2010 [cited by applicant]
JP 2011212441A2 · 2011 [cited by applicant]
JP 2018503885A · 2018 [cited by applicant]
WO 1983004171A1 · 1983 [cited by applicant]
WO 1998039061A2 · 1998 [cited by applicant]
WO 2004078259A1 · 2004 [cited by applicant]
WO WO2008036396A2 · 2008 [cited by applicant]
WO 2009031149A2 · 2009 [cited by applicant]
WO 2009122277A2 · 2009 [cited by applicant]
WO 2012006524A1 · 2012 [cited by applicant]
WO 2013130957A2 · 2013 [cited by applicant]
WO 2014097035A1 · 2014 [cited by applicant]
WO WO2015134556A1 · 2015 [cited by applicant]
American Journal of Respiratory and Critical Care Medicine, vol. 166, pp. 111-117 (2002), American Thoracic Society, ATS Statement: Guidelines for the Six-Minute Walk Test, available at http://ajrccm.atsjournals.org/cgi… [cited by applicant]
PCT Search Report and Written Opinion for PCT Application No. PCT/US19/22553, mailed on Jun. 11, 2019, 13 pages. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2019/022553 dated Sep. 22, 2020, 11 pages. [cited by applicant]
Association for the Advancement of Medical Instrumentation, ANSI/AAME DF80:2003 Medical Electrical Equipment—Part 2-4: Particular Requirements for the Safety of Cardiac Defibrillators (including Automated External Defib… [cited by applicant]
Bohadana et al., “Fundamentals of Lung Auscultation”, N Engl J Med, 370:744-751 (2014). [cited by applicant]
Zoll Medical Corporation, LifeVest Model WCD 3000 Operator's Manual, 2012, Pittsburgh, PA. [cited by applicant]
http://web.archive.org/web/20030427001846/http:/www.lifecor.comiimagelib/imageproduct.asp. Published by LifeCor, Inc., 2002, on a webpage owned by LifeCor, Inc. [cited by applicant]
Köhler et al., “The Principles of Software QRS Detection”, IEEE Engineering in Medicine and Biology Magazine, 21 (1):42-57 (Feb. 2002). [cited by applicant]